The oncology precision medicine industry is rapidly evolving as cutting-edge technologies increasingly enable personalized cancer treatments tailored to patients’ genetic profiles. Fueled by innovations in genomics and bioinformatics, this sector is witnessing significant advances in targeted therapies, driving transformative outcomes in oncology care and reshaping treatment paradigms...

The clinical trial software industry is witnessing significant transformation driven by technological advancements and increased demand for streamlined drug development processes. With growing complexities in clinical trials and a focus on data integrity, this sector is poised for accelerated growth, aligned with dynamic market trends and emerging opportunities.Market Size and Overview The...

The Retinal Vein Occlusion industry is witnessing significant transformation driven by advancements in therapeutics and increasing prevalence of retinal vascular diseases worldwide. This dynamic market landscape reflects robust business growth, propelled by novel drug development and expanding patient awareness, which are influencing the industry size and market forecast for the upcoming...

The global 3-hydroxyphenyl phosphinyl propanoic acid market is valued at USD 49.69 million in 2026 and is projected to reach USD 74.98 million by 2036, expanding at a CAGR of 4.2% from 2026 to 2036. Growth is primarily driven by increasing pharmaceutical research and development activities, alongside rising demand for phosphorus-containing intermediates used in drug synthesis and catalytic...

The global 3-hydroxyphenyl phosphinyl propanoic acid market is valued at USD 49.69 million in 2026 and is projected to reach USD 74.98 million by 2036, expanding at a CAGR of 4.2% from 2026 to 2036. Growth is primarily driven by increasing pharmaceutical research and development activities, alongside rising demand for phosphorus-containing intermediates used in drug synthesis and...

The integration of fluorine atoms into organic molecules has revolutionized the pharmaceutical industry. The presence of fluorine dramatically alters a drug's physicochemical properties, enhancing its metabolic stability, increasing its lipophilicity for better cell membrane penetration, and improving its binding affinity to target proteins. However, synthesizing these complex fluorinated...

AI in Cancer Treatment: Accelerating Therapeutic Discovery and Redefining the Sunitinib Malate Market Introduction Artificial intelligence is no longer a futuristic abstraction for the healthcare sector it is an active, transformative force reshaping how cancer is detected, classified, and treated. From deep learning algorithms that identify malignant lesions in radiological images to natural...

AI In Clinical Trials Market Size, Share, Growth Analysis, and Industry Report The AI In Clinical Trials Market research report delivers comprehensive insights into market size, growth trends, key drivers, challenges, and emerging opportunities for the period 2026–2035. The study provides an in-depth analysis of the factors influencing market growth, including industry...

The global AI in Clinical Trials Market advances in generative AI for protocol authoring, digital twins, synthetic control arms, natural language processing for EHR matching, and predictive outcome modeling are transforming how trials are designed and executed. According to Business Market Insights, the AI in Clinical Trials Market size was valued at US$ 4.10 Billion in 2025 and is projected to...

The AI in Clinical Trials market is poised for significant transformation as artificial intelligence integrates deeper into the clinical development landscape, driving efficiency and accuracy. This industry is rapidly evolving through innovative applications of AI that optimize trial design, patient recruitment, and data analysis, shaping the future of clinical research with unprecedented scale...

The global amyloidosis treatment market is poised for strong growth as healthcare systems increasingly prioritize rare disease management, precision medicine, and advanced therapeutic interventions. Valued at USD 6.2 billion in 2025, the market is projected to reach USD 12.9 billion by 2035, growing at a 7.5% CAGR during the forecast period. Growth is increasingly driven by therapeutic...

Angiogenesis Inhibitors and Stimulators Market to Reach USD 67.17 Billion by 2032, Growing at 9.3% CAGR: Polaris Market Research Polaris Market Research reports that the global angiogenesis inhibitors and stimulators market was valued at USD 27.61 billion in 2022 and is projected to reach USD 67.17 billion by 2032, expanding at a CAGR of 9.3% during the forecast period. The report examines...

The global antibody specificity testing market is poised for steady expansion as research institutions, pharmaceutical companies, and diagnostic laboratories increasingly prioritize experimental accuracy, regulatory compliance, and reproducible scientific outcomes. Valued at USD 1,008.5 million in 2025, the market is projected to reach USD 2,090.3 million by 2035, growing at a 7.6% CAGR during...

According to the latest report published by Data Bridge Market Research, the Array-based Systems Market  CAGR Value The global array-based systems market size was valued at USD 5.20 billion in 2025 and is expected to reach USD 9.11 billion by 2033, at a CAGR of 7.27% during the forecast period This Array-based Systems Market research report is...

Beyond early research, the artificial intelligence (AI) in pharmaceutical market is increasingly tied to clinical development and underserved therapeutic areas. Polaris Market Research values the market at USD 2.48 billion in 2025 and projects USD 28.63 billion by 2034, a CAGR of 31.2% from 2026 to 2034. This article focuses on where AI can improve trial execution, expand research into complex...

The Artificial Intelligence in Drug Discovery industry is transforming the pharmaceutical landscape by accelerating drug development pipelines and enhancing predictive accuracy. This rapidly evolving sector is marked by increasing adoption of AI-driven analytics, machine learning algorithms, and computational modeling to concretely improve drug candidate identification and reduce...

Polaris Market Research announces the release of its latest research report Asia Pacific Veterinary Clinical Trials Market. The newly published report captures all the key forces influencing market transformation. As industries evolve amid technological shifts, economic disruptions, and regulatory changes, the study outlines how the market is responding and where it is headed. Designed to...

The global big data analytics in healthcare market is expected to be worth US$ 39.7 billion in fiscal year 2022, up from US$ 33.8 billion in fiscal year 2021. From 2022 to 2032, the market is expected to grow at a 19.2% CAGR, reaching a value of US$ 194.7 billion by the end of 2032. big data analytics in healthcare market size According to the...

The biliary tract cancers (BTCs) industry is witnessing steady expansion driven by advancements in targeted therapies and diagnostic techniques. With increasing investments focused on oncology drug development and rising awareness about early diagnosis, the market dynamics are shifting towards personalized and value-based care solutions. This evolving landscape reflects significant...

According to a new report by Polaris Market Research, the global biological safety testing products and services market was valued at USD 6.2 billion in 2024 and is projected to reach USD 19.8 billion by 2034, expanding at a CAGR of 12.90% over the forecast period, with 2025 revenue estimated at USD 7 billion. Growth is underpinned by stringent regulatory requirements for...